Science

AddToAny

Google+ Facebook Twitter Twitter

Covid-19 and haemostasis screening: the expected and the unexpected

Senior Biomedical Scientist Clare Wigley and colleagues take us through how their lab processes and workflow changed during the waves of the COVID-19 pandemic.

In early 2020, as news broke of COVID-19 cases being diagnosed across the UK, our laboratory began to prepare for an influx of patients. Being based at St Thomas’ Hospital in London, we knew that our hospital would be accepting early COVID-19 patients. We also knew that these people could be seriously ill, as we are one of six UK centres commissioned to provide adult respiratory extracorporeal membrane oxygen (ECMO) support. The little we knew about this new virus included reports of thrombosis and abnormal coagulation parameters.

Our laboratory is split into two sections – a high-throughput laboratory that deals with coagulation screening, known locally as the “routine laboratory”, and a specialist haemostasis service. However, “routine” was about to become far from routine.

We were advised that elective surgeries and outpatient clinics would be paused so that the trust could focus its resources on the pandemic because, as well as dealing with seriously ill patients, we also needed to prepare for changes to our workforce. With so much still unknown, the guidance at the time was that vulnerable staff would need to shield or work from home – something not entirely compatible with our usual laboratory work.

Please click here to read the full article.

Image credit | Science Picture Library

Related Articles

web_blood-testing_credit_istock-1384651794.png

SPONSORED: The power of automated gel-based ID-cards in routine immunohematology workflows

Immuno-haematology assays are pivotal to the carrying out of blood grouping, antibody screening and transfusions, and represent a critically time-dependent stage in the patient management pathway.

Technician holding a blood sample ready for testing with other human medical samples in the background.-Image credit - Science-Photo-Library-f0243823

Machine learning tool to detect cancer via liquid biopsy

US researchers have developed and tested an innovative machine-learning approach that could one day enable the earlier detection of cancer in patients by using smaller blood draws.

multiple myelomatosis-CREDIT-Science Photo Library-m132099

IBMS research grants

We look at the work of Dr Mosavar Farahani who received an IBMS Research Grant in 2023 to help fund her work on disease progression and skeletal complications in multiple myeloma.

Jaxon Moran and Emily Jones

My Lab: Flow cytometry laboratory

Jaxon Moran and Emily Jones give a guided tour of the Flow Cytometry Laboratory at Newcastle upon Tyne Hospitals NHS Foundation Trust.

Top